NCT00005990View on ClinicalTrials.gov

R115777 Plus Topotecan in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2000

Primary Completion Date

September 30, 2006

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

tipifarnib

DRUG

topotecan hydrochloride

Trial Locations (1)

10016

NYU Cancer Institute at New York University Medical Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

NYU Langone Health

OTHER

NCT00005990 - R115777 Plus Topotecan in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter